Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Май 8, 2025
Toll-like
receptor
3
(TLR3)
is
a
pattern
recognition
known
to
play
crucial
role
in
the
immune
response
cancer.
However,
its
effect
on
efficacy
of
immunotherapy
lung
adenocarcinoma
(LUAD)
remains
unclear.
This
study
aims
investigate
TLR3
LUAD
by
examining
expression
levels,
prognostic
significance,
and
impact
signaling
pathways.
We
analyzed
prognosis
patients
using
data
from
Cancer
Genome
Atlas
(TCGA)
database
four
additional
cohorts
(GSE72094,
GSE30219,
GSE50081
GSE31210).
Functional
enrichment
analyses
were
performed
compare
molecular
features
between
low
high
groups
gene
set
variation
analysis
(GSVA).
also
examined
correlation
tumor
mutation
burden
(TMB),
infiltration,
PD-L1
expression.
Further
experimental
validation
was
conducted
co-culture
systems
cells
peripheral
blood
mononuclear
(PBMCs)
with
PD1
inhibitors,
Western
blot
involvement
NF-κB
signaling.
significantly
lower
tissues
compared
normal
tissues,
correlating
better
survival
outcomes
across
multiple
cohorts.
High
associated
increased
TMB
enhanced
activation.
Patients
exhibited
higher
checkpoint
cell
infiltration.
Experimental
results
showed
that
agonists
susceptibility
activated
PBMCs
under
inhibitor
therapy,
inhibiting
proliferation,
migration,
invasion.
Additionally,
has
strong
positive
MHC
molecules
upregulated
identified
as
key
regulator
expression,
enhancing
activity.
enhances
anti-tumor
modulating
making
it
promising
biomarker
therapeutic
target.
highlights
potential
improve
outcomes,
providing
comprehensive
paving
way
for
novel
strategies
targeting
TLR3-mediated
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Май 19, 2022
Innate
and
adaptive
immunity
represent
a
harmonic
counterbalanced
system
involved
in
the
induction,
progression,
possibly
resolution
of
inflammatory
reaction
that
characterize
autoimmune
rheumatic
diseases
(ARDs),
including
rheumatoid
arthritis
(RA).
Although
immunopathophysiological
mechanisms
ARDs
are
not
fully
clarified,
they
often
associated
with
an
inappropriate
macrophage/T-cell
interaction,
where
classical
(M1)
or
alternative
(M2)
macrophage
activation
may
influence
occurrence
T-helper
(Th)1
Th2
responses.
In
RA
patients,
M1/Th1
occurs
environment
dominated
by
Toll-like
receptor
(TLR)
interferon
(IFN)
signaling,
it
promotes
massive
production
pro-inflammatory
cytokines
[i.e.,
tumor
necrosis
factor-α
(TNFα),
interleukin
(IL)-1,
IL-12,
IL-18,
IFNγ],
chemotactic
factors,
matrix
metalloproteinases
resulting
osteoclastogenesis,
erosion,
progressive
joint
destruction.
On
other
hand,
M2/Th2
response
determines
release
growth
factors
IL-4,
IL-10,
IL-13,
transforming
factor
(TGF)-β]
anti-inflammatory
process
leading
to
clinical
remission
RA.
Several
subtypes
macrophages
have
been
described.
Five
polarization
states
from
M1
M2
confirmed
vitro
studies
analyzing
morphological
characteristics,
gene
expression
phenotype
markers
(CD80,
CD86,
TLR2,
TLR4,
CD206,
CD204,
CD163,
MerTK),
functional
aspect,
reactive
oxygen
species
(ROS).
An
imbalance
induce
pathological
consequences
contribute
several
diseases,
such
as
asthma
osteoclastogenesis
patients.
addition,
dynamic
includes
presence
intermediate
polarity
stages
distinguished
specific
surface
production/release
distinct
molecules
(i.e.,
nitric
oxide,
cytokines),
which
their
state.
This
suggests
"continuum"
playing
important
role
during
inflammation
its
resolution.
review
discusses
importance
delicate
M1/M2
different
phases
together
identification
pathways,
cytokines,
chemokines
involved,
outcomes
The
analysis
these
aspects
could
shed
light
on
abnormal
activation,
novel
therapeutical
approaches
restore
balance.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Апрель 10, 2024
Macrophages
are
crucial
cells
in
the
human
body's
innate
immunity
and
engaged
a
variety
of
non-inflammatory
reactions.
can
develop
into
two
kinds
when
stimulated
by
distinct
internal
environments:
pro-inflammatory
M1-like
macrophages
anti-inflammatory
M2-type
macrophages.
During
inflammation,
activated
alternatively,
maintaining
reasonably
steady
ratio
is
critical
for
homeostasis
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Май 3, 2024
Accumulating
studies
have
indicated
that
the
gut
microbiota
plays
a
pivotal
role
in
onset
of
autoimmune
diseases
by
engaging
complex
interactions
with
host.
This
review
aims
to
provide
comprehensive
overview
existing
literatures
concerning
relationship
between
and
diseases,
shedding
light
on
interplay
microbiota,
host
immune
system.
Furthermore,
we
aim
summarize
impacts
potential
mechanisms
underlie
primarily
focusing
systemic
lupus
erythematosus,
rheumatoid
arthritis,
Sjögren’s
syndrome,
type
1
diabetes
mellitus,
ulcerative
colitis
psoriasis.
The
present
will
emphasize
clinical
significance
applications
interventions
based
as
innovative
adjunctive
therapies
for
diseases.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(9), С. 5037 - 5037
Опубликована: Май 5, 2024
Toll-like
receptors
(TLRs)
are
vital
components
of
the
innate
immune
system,
serving
as
first
line
defense
against
pathogens
by
recognizing
a
wide
array
molecular
patterns.
This
review
summarizes
critical
roles
TLRs
in
surveillance
and
disease
pathogenesis,
focusing
on
their
structure,
signaling
pathways,
implications
various
disorders.
We
discuss
intricacies
TLRs,
including
ligand
specificity,
cascades,
functional
consequences
activation.
The
involvement
infectious
diseases,
autoimmunity,
chronic
inflammation,
cancer
is
explored,
highlighting
potential
therapeutic
targets.
also
examine
recent
advancements
TLR
research,
such
development
specific
agonists
antagonists,
application
immunotherapy
vaccine
development.
Furthermore,
we
address
challenges
controversies
surrounding
research
outline
future
directions,
integration
computational
modeling
personalized
medicine
approaches.
In
conclusion,
represent
promising
frontier
medical
with
to
significantly
impact
novel
strategies
for
range
diseases.
Frontiers in Cellular Neuroscience,
Год журнала:
2021,
Номер
15
Опубликована: Июнь 24, 2021
Air
pollution
is
regarded
as
an
important
risk
factor
for
many
diseases
that
affect
a
large
proportion
of
the
human
population.
To
date,
accumulating
reports
have
noted
particulate
matter
(PM)
closely
associated
with
course
cardiopulmonary
disorders.
As
incidence
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
and
autoimmune
disorders
risen
world’s
population
aging,
there
increasing
interest
in
environmental
health
hazards,
mainly
air
pollution,
which
has
been
slightly
overlooked
one
plausible
detrimental
stimuli
contributing
to
neurodegenerative
onset
progression.
Epidemiological
studies
indicated
noticeable
association
between
exposure
PM
neurotoxicity,
gradually
confirmed
by
vivo
vitro
studies.
After
entering
body
directly
through
olfactory
epithelium
or
indirectly
passing
respiratory
system
into
circulatory
system,
pollutants
are
subsequently
able
reach
brain.
Among
potential
mechanisms
underlying
particle-induced
effects
periphery
central
nervous
(CNS),
increased
oxidative
stress,
inflammation,
mitochondrial
dysfunction,
microglial
activation,
disturbance
protein
homeostasis,
ultimately,
neuronal
death
often
postulated
concomitantly
coincide
main
pathomechanisms
processes.
Other
complementary
could
mediate
neurotoxicity
contribute
neurodegeneration
remain
unconfirmed.
Furthermore,
question
how
strong
proven
substantial
adverse
factors
etiologies
remains
unsolved.
This
review
highlights
research
advances
regarding
issue
emphasis
on
markers,
symptoms,
damage
CNS.
Poor
quality
insufficient
knowledge
its
toxicity
justify
conducting
scientific
investigations
understand
biological
impact
context
various
types
neurodegeneration.
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Авг. 1, 2022
Objective
To
evaluate
the
randomized
controlled
trials
(RCTs)
of
Curcumin
and
Curcuma
longa
Extract
in
treatment
autoimmune
diseases.
Methods
Databases
such
as
Embase,
Web
Science,
PubMed
The
Cochrane
Library
were
searched
from
database
establishment
to
February
2022
collect
RCTs
Then
literature
was
screened
data
extracted.
Meta-analysis
performed
using
RevMan
5.3
software.
Results
A
total
34
records
included,
involving
31
10
types
disease.
Among
them,
ankylosing
spondylitis
(AS)
involves
one
RCT,
Behcet
‘s
disease
(BD)
Crohn
two
RCTs,
multiple
sclerosis
(MS)
oral
lichen
planus
six
psoriasis
rheumatoid
arthritis
(RA)
five
systemic
lupus
erythematosus
(SLE)
arteritis
ulcerative
colitis
(UC)
nine
RCTs.
most
(UC),
planus,
RA
showed
that
curcumin
extracts
improved
clinical
or
laboratory
results.
‘
s
disease,
MS,
SLE,
included
RCTs;
they
all
improvements
(at
least
RCT
reported
outcomes).
AS,
BD
only
results
improvement.
However,
due
small
number
patients
involved
each
there
is
still
a
need
for
more
high-quality
Conclusion
had
good
efficacy
Psoriasis,
UC
RA,
so
could
be
used
above
diseases
future.
did
not
show
while
Takayasu
arteritis,
CD
report
sufficient
meta-analysis.
Therefore,
large-sample,
multi-center
are
needed
revision
validation.
Abstract
The
subcellular
localization
and
intracellular
trafficking
of
Toll‐like
receptors
(TLRs)
critically
regulate
TLRs‐mediated
antimicrobial
immunity
autoimmunity.
Here,
it
is
demonstrated
that
the
E3
ubiquitin
ligase
RNF115
inhibits
post‐endoplasmic
reticulum
(ER)
TLRs
immune
responses
by
catalyzing
ubiquitination
small
GTPases
RAB1A
RAB13.
It
shown
14‐3‐3
chaperones
bind
to
AKT1‐phosphorylated
facilitate
localizing
on
ER
Golgi
apparatus.
interacts
with
RAB13
catalyzes
K11‐linked
Lys49
Lys61
residues
Lys46
Lys58
RAB13,
respectively.
Such
a
modification
impairs
recruitment
guanosine
diphosphate
(GDP)
dissociation
inhibitor
1
(GDI1)
prerequisite
for
reactivation
RAB
proteins.
Consistently,
knockdown
in
Rnf115
+/+
−/−
cells
markedly
post‐ER
post‐Golgi
TLRs,
In
addition,
reconstitution
K49/61R
or
K46/58R
into
but
not
promotes
from
apparatus
cell
surface,
These
findings
uncover
common
step‐wise
regulatory
mechanism
TLRs.